How do breast cancer clinical trials approach cardiovascular safety: targeted or generalized?

被引：0
|
作者：
Arsalan Hamid
Gregg C. Fonarow
Javed Butler
Michael E. Hall
机构：
[1] University of Mississippi Medical Center,Department of Medicine
[2] David Geffen School of Medicine at UCLA,Division of Cardiology
[3] Baylor Scott and White Research Institute,Department of Medicine, Division of Cardiology
[4] University of Mississippi Medical Center,undefined
来源：
Cardio-Oncology | / 10卷
关键词：
Breast cancer; Clinical trials; Cardiovascular safety; Prevent cardiotoxicity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Increasing minority accrual in breast cancer clinical trials through a multidisciplinary approach
    Largaespada, Valesca
    Hurst, Samantha
    Bradley, Savannah M.
    Acosta, Myriam, I
    Unkart, Jonathan
    Blair, Sarah
    Nodora, Jesse
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2020, 29 (06)
  • [32] Decision-making and breast cancer clinical trials -: How experience challenges attitudes
    Mancini, Julien
    Geneve, Jean
    Dalenc, Florence
    Genre, Dominique
    Monnier, Alain
    Kerbrat, Pierre
    Largillier, Remy
    Serin, Daniel
    Rios, Maria
    Roche, Henri
    Jimenez, Marta
    Tarpin, Carole
    Reynier, Claire Julian
    CONTEMPORARY CLINICAL TRIALS, 2007, 28 (06) : 684 - 694
  • [33] A National Cancer Clinical Trials System for Targeted Therapies
    Mendelsohn, John
    SCIENCE TRANSLATIONAL MEDICINE, 2011, 3 (75)
  • [34] GLOBAL DISTRIBUTION OF CLINICAL TRIALS FOR TARGETED CANCER THERAPIES
    Zhao, A.
    Li, M.
    VALUE IN HEALTH, 2020, 23 : S56 - S56
  • [35] HOW DO CLINICAL-TRIALS INFLUENCE CLINICAL-PRACTICE
    LENFANT, C
    CARDIOVASCULAR MEDICINE, 1986, 11 (03): : 61 - 62
  • [36] An update on clinical trials of targeted therapies in thyroid cancer
    Haraldsdottir, Sigurdis
    Shah, Manisha H.
    CURRENT OPINION IN ONCOLOGY, 2014, 26 (01) : 36 - 44
  • [37] An update on clinical trials of targeted therapies in thyroid cancer
    Haraldsdottir, Sigurdis
    Shah, Manisha H.
    ONCOLOGY IN CLINICAL PRACTICE, 2014, 10 (02): : 121 - 130
  • [38] Cardiovascular safety profile of rofecoxib in controlled clinical trials.
    Daniels, B
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S143 - S143
  • [39] Cardiac safety evaluation in cancer clinical trials
    Gujral, Dorothy M.
    Cleator, Susan J.
    Bhattacharyya, Sanjeev
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : 143 - 146
  • [40] How Do We Define Efficacy in Comparing Osteoclast-Targeted Agents in Metastatic Breast Cancer?
    Gralow, Julie R.
    Lipton, Allan
    Stopeck, Alison T.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (26) : 3591 - 3592
12345